Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
American Healthcare REITAHR +1.32%49 EV-to-EBITDA is 26.14 as of Aug. 16, 2026, which is 7% above its 10-year median of 24.49. GuruFocus rates AHR with a GF Score™ of 49/100 and a GF Value™ of $31.27 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 674 REITs companies, American Healthcare REIT ranks worse than 84.57% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, American Healthcare REIT's enterprise value is $11,925 Mil.
American Healthcare REIT's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $456 Mil. Therefore, American Healthcare REIT's EV-to-EBITDA for today is 26.14.
The historical rank and industry rank for American Healthcare REIT's EV-to-EBITDA or its related term are showing as below:
AHR'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.11 Med: 24.49 Max: 31.67
Current: 26.14
During the past 6 years, the highest EV-to-EBITDA of American Healthcare REIT was 31.67. The lowest was 11.11. And the median was 24.49.
AHR's EV-to-EBITDA is ranked worse than 84.57% of 674
companies
in the REITs industry
Industry Median: 15.4
vs AHR: 26.14
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
American Healthcare REIT (NYSE:AHR) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
American Healthcare REIT's PE Ratio (TTM) for today is calculated as:
American Healthcare REIT's share price for today is $54.31.
American Healthcare REIT's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.680.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, American Healthcare REIT's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Healthcare REIT EV-to-EBITDA vs REITs Industry
For the REITs industry and Real Estate sector, American Healthcare REIT's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where American Healthcare REIT's EV-to-EBITDA falls into.
American Healthcare REIT's current Enterprise Value is $11,925 Mil.
American Healthcare REIT's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $456 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Healthcare REIT (AHR) has a EV-to-EBITDA of 26.14 as of Aug. 16, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on American Healthcare REIT. This is near median its historical median of 24.49. Over the past decade, American Healthcare REIT's EV-to-EBITDA has ranged from 11.11 to 31.67. According to the industry distribution chart, American Healthcare REIT ranks #570 out of 674 companies in the REITs industry, placing it in the top 84.6%.
Is American Healthcare REIT's EV-to-EBITDA too high?
American Healthcare REIT's current EV-to-EBITDA of 26.14 is near median its 10-year median of 24.49. Over the past 10 years, this metric has ranged from a low of 11.11 to a high of 31.67. The REITs industry median EV-to-EBITDA is 15.40. American Healthcare REIT's value of 26.14 is 69.7% above this industry median. Based on the distribution chart, American Healthcare REIT ranks #570 out of 674 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, American Healthcare REIT has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does American Healthcare REIT's EV-to-EBITDA compare to CTRE and HR?
According to the REITs industry distribution chart, American Healthcare REIT ranks #570 out of 674 companies for EV-to-EBITDA. This places American Healthcare REIT in the lower half of its industry. The industry median EV-to-EBITDA is 15.40. American Healthcare REIT's value of 26.14 is 69.7% above this benchmark. Historically, American Healthcare REIT's own EV-to-EBITDA has ranged from 11.11 to 31.67 over the past decade. While the company's 10-year median is 24.49 vs. the industry median of 15.40, American Healthcare REIT has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a REITs company?
The median EV-to-EBITDA among REITs companies is 15.40, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. American Healthcare REIT's current EV-to-EBITDA of 26.14 is 69.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on American Healthcare REIT. For the REITs industry, the median EV-to-EBITDA is 15.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. American Healthcare REIT's current EV-to-EBITDA is 26.14, which is near median its own 10-year median of 24.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Healthcare REIT stock overvalued right now?
Based on GuruFocus' analysis, American Healthcare REIT (AHR) is currently considered Significantly Overvalued. The stock's GF Value™ is $31.27, compared to a current price of $54.31 — trading 73.7% above its estimated fair value. The current EV-to-EBITDA is 26.14, which is near median its 10-year median of 24.49 and 69.7% above the REITs industry median of 15.40. American Healthcare REIT's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For American Healthcare REIT (AHR), the current EV-to-EBITDA is 26.14 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is American Healthcare REIT (AHR) Overvalued in 2026?
Based on GuruFocus' analysis, American Healthcare REIT stock appears to be overvalued.
The current stock price of $54.31 is trading 73.7% above its estimated GF Value™ of $31.27.
GuruFocus considers American Healthcare REIT to be Significantly Overvalued.
Key valuation signals for AHR:
EV-to-EBITDA: 26.14 (near median its 10-year median of 24.49)
GF Value™: $31.27 vs. price of $54.31 (73.7% above fair value)
Industry Position: 69.7% above the REITs median (#570 of 674)
No single metric tells the full story. See the AHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
49GF Score
Get the complete analysis for AHR
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AHR has been successfully added to your 
